Shahram Salek-Ardakani

11PUBLICATIONS
20CO-AUTHORS
AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 25, 2024
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer.

Michael Croft, Shahram Salek-Ardakani, Carl F Ware

|Dec 14, 2021
Combinatorial immunotherapy induces tumor-infiltrating CD8+ T cells with distinct functional, migratory, and stem-like properties.

Natalija Van Braeckel-Budimir, Joseph Samuel Dolina, Jie Wei

|Oct 02, 2021
Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity.

Shih-Hsun Chen, Pawel K Dominik, Jessica Stanfield

|Feb 27, 2021
CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.

Paola Marie Marcovecchio, Graham Thomas, Shahram Salek-Ardakani

|Sep 09, 2020
FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells.

Lucia Campos Carrascosa, Adriaan A van Beek, Valeska de Ruiter

|Jun 01, 2020
CD40 agonist-induced IL-12p40 potentiates hepatotoxicity.

Caroline Bonnans, Graham Thomas, Wenqian He

Pageof 2